Maternal Gestational TMC3115 Treatment Shapes Construction of Offspring Gut Microbiota and Development of Immune System and Induces Immune Tolerance to Food Allergen

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2022 Dec 1

PMID 36452299

Authors

Ruyue Cheng

Yujie Zhang

Yang Yang

Lei Ren

Jinxing Li

Yimei Wang

Xi Shen

Fang He

Affiliations

Soon will be listed here.

Abstract

In this study we aimed to determine whether treatment with maternal TMC3115 could affect the composition of the gut microbiota and the development of the immune system and intestinal tract of offspring, and protect the offspring from IgE-mediated allergic disease. Pregnant BALB/c mice were gavaged with TMC3115 until delivery. Offspring were sensitized with ovalbumin from postnatal days 21 to 49. After maternal treatment with TMC3115, the microbiota of the offspring's feces, intestinal contents, and stomach contents (a proxy for breast milk) at the newborn and weaning stages exhibited the most change, and levels of immunoglobulin in the sera and stomach contents and of splenic cytokines, as well as the mRNA levels of colonic intestinal development indicators were all significantly altered in offspring at different stages. After sensitization with ovalbumin, there were no significant changes in the levels of serum IgE or ovalbumin-specific IgE/IgG1 in the TMC3115 group; however, IgM, the expression of intestinal development indicators, and the production of fecal short chain fatty acid (SCFA) were significantly increased, as were the relative abundances of and the NK4A136 group. Our results suggested that maternal treatment with TMC3115 could have a profound modulatory effect on the composition of the gut microbiota and the development of the immune system and intestinal tissue in offspring at different stages of development, and may induce immune tolerance to allergens in ovalbumin-stimulated offspring by modulating the gut microbiota and SCFA production.

Citing Articles

Characteristics of the effects of Polygonati Rhizoma on gut microbiota and metabolites in vitro associated with poor dietary habits in pregnant women.

Xu Z, Li J, Hong L, Zhang Y, Wang C, Yang H PLoS One. 2024; 19(12):e0314335.

PMID: 39637062 PMC: 11620700. DOI: 10.1371/journal.pone.0314335.

Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance.

Liu Y, Zhou J, Yang Y, Chen X, Chen L, Wu Y Vaccines (Basel). 2024; 12(8).

PMID: 39203994 PMC: 11359036. DOI: 10.3390/vaccines12080868.

An In Vitro Evaluation of the Effect of Bifidobacterium longum L556 on Microbiota Composition and Metabolic Properties in Patients with Coronary Heart Disease (CHD).

Yang L, Wu Y, Zhao X, Liang T, Li L, Yang J Probiotics Antimicrob Proteins. 2024; .

PMID: 38722549 DOI: 10.1007/s12602-024-10267-7.

Feast for thought: A comprehensive review of food allergy 2021-2023.

Bartha I, Almulhem N, Santos A J Allergy Clin Immunol. 2023; 153(3):576-594.

PMID: 38101757 PMC: 11096837. DOI: 10.1016/j.jaci.2023.11.918.

References

Stuivenberg G, Burton J, Bron P, Reid G . Why Are Bifidobacteria Important for Infants?. Microorganisms. 2022; 10(2). PMC: 8880231. DOI: 10.3390/microorganisms10020278. View

Li L, Han Z, Niu X, Zhang G, Jia Y, Zhang S . Probiotic Supplementation for Prevention of Atopic Dermatitis in Infants and Children: A Systematic Review and Meta-analysis. Am J Clin Dermatol. 2018; 20(3):367-377. DOI: 10.1007/s40257-018-0404-3. View

Kim J, Kwon J, Ahn S, Lee S, Han Y, Choi Y . Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2009; 21(2 Pt 2):e386-93. DOI: 10.1111/j.1399-3038.2009.00958.x. View

Ronan V, Yeasin R, Claud E . Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development. Gastroenterology. 2020; 160(2):495-506. PMC: 8714606. DOI: 10.1053/j.gastro.2020.08.065. View

Cheng R, Guo J, Pu F, Wan C, Shi L, Li H . Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood. Sci Rep. 2019; 9(1):3254. PMC: 6397183. DOI: 10.1038/s41598-018-35737-1. View

Cheng R, Li M, Li S, He M, Yu X, Shi L . Vancomycin and ceftriaxone can damage intestinal microbiota and affect the development of the intestinal tract and immune system to different degrees in neonatal mice. Pathog Dis. 2017; 75(8). DOI: 10.1093/femspd/ftx104. View

He F, Ouwehand A, Isolauri E, Hashimoto H, Benno Y, Salminen S . Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001; 30(1):43-7. DOI: 10.1111/j.1574-695X.2001.tb01548.x. View

Moeller A, Caro-Quintero A, Mjungu D, Georgiev A, Lonsdorf E, Muller M . Cospeciation of gut microbiota with hominids. Science. 2016; 353(6297):380-2. PMC: 4995445. DOI: 10.1126/science.aaf3951. View

Shao Y, Forster S, Tsaliki E, Vervier K, Strang A, Simpson N . Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019; 574(7776):117-121. PMC: 6894937. DOI: 10.1038/s41586-019-1560-1. View

10.

Thorburn A, McKenzie C, Shen S, Stanley D, Macia L, Mason L . Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015; 6:7320. DOI: 10.1038/ncomms8320. View

11.

Al Nabhani Z, Dulauroy S, Marques R, Cousu C, Al Bounny S, Dejardin F . A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult. Immunity. 2019; 50(5):1276-1288.e5. DOI: 10.1016/j.immuni.2019.02.014. View

12.

Gensollen T, Blumberg R . Correlation between early-life regulation of the immune system by microbiota and allergy development. J Allergy Clin Immunol. 2017; 139(4):1084-1091. PMC: 5402752. DOI: 10.1016/j.jaci.2017.02.011. View

13.

Nyangahu D, Lennard K, Brown B, Darby M, Wendoh J, Havyarimana E . Disruption of maternal gut microbiota during gestation alters offspring microbiota and immunity. Microbiome. 2018; 6(1):124. PMC: 6035804. DOI: 10.1186/s40168-018-0511-7. View

14.

Gotoh A, Katoh T, Sakanaka M, Ling Y, Yamada C, Asakuma S . Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci Rep. 2018; 8(1):13958. PMC: 6143587. DOI: 10.1038/s41598-018-32080-3. View

15.

Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub A . Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2018; 220(4):324-335. DOI: 10.1016/j.ajog.2018.11.1089. View

16.

Owen C . Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Pharmacol Ther. 2006; 113(1):121-33. DOI: 10.1016/j.pharmthera.2006.07.003. View

17.

Shen X, Wang M, Zhang X, He M, Li M, Cheng G . Dynamic construction of gut microbiota may influence allergic diseases of infants in Southwest China. BMC Microbiol. 2019; 19(1):123. PMC: 6558729. DOI: 10.1186/s12866-019-1489-4. View

18.

Kimura I, Miyamoto J, Ohue-Kitano R, Watanabe K, Yamada T, Onuki M . Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science. 2020; 367(6481). DOI: 10.1126/science.aaw8429. View

19.

Loh W, Tang M . Adjuvant Therapies in Food Immunotherapy. Immunol Allergy Clin North Am. 2017; 38(1):89-101. DOI: 10.1016/j.iac.2017.09.008. View

20.

Perez P, Dore J, Leclerc M, Levenez F, Benyacoub J, Serrant P . Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics. 2007; 119(3):e724-32. DOI: 10.1542/peds.2006-1649. View